FK
Faisal Khurshid Jefferies Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
19
Avg Return
Past Year
Past Year
77%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
73.3%
Neutral
26.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $15 |
40%
upside
| 1 | +7.4% |
0
%
| 16 Mar ‘26 3 months ago |
|
|
|
Buy
Initiated
| $160 |
63%
upside
| 1 | +6.1% |
0
%
| 16 Mar ‘26 3 months ago |
|
|
|
Hold
Downgraded
| $290 |
9%
upside
| 1 | – |
–
| 16 Mar ‘26 3 months ago |
|
|
|
Hold
Downgraded
| $330 |
18%
upside
| 1 | – |
–
| 16 Mar ‘26 3 months ago |
|
|
|
Hold
Downgraded
| $94 |
7%
downside
| 1 | – |
–
| 16 Mar ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $118 |
38%
upside
| 1 | -14% |
0
%
| 9 Dec ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $16 |
12%
upside
| 1 | +2.7% |
0
%
| 20 Nov ‘25 6 months ago |
|
|
|
Market Perform
Downgraded
| $4 |
22%
downside
| 2 | +19% |
0
%
| 7 Nov ‘25 7 months ago |
|
|
|
Outperform
Upgraded
| $40 |
43%
upside
| 1 | -5% |
0
%
| 21 Oct ‘25 7 months ago |
|
|
|
Outperform
Initiated
| $20 |
58%
upside
| 1 | +24% |
0
%
| 25 Sep ‘25 8 months ago |
|
|
|
Outperform
Initiated
| $73 |
34%
downside
| 1 | +61% |
0
%
| 12 Sep ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $2 |
54%
downside
| 2 | +304% |
0
%
| 14 Aug ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $102 |
13%
upside
| 2 | +18% |
0
%
| 10 Jul ‘25 11 months ago |
|